Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19238219 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
Condition: Malaria
Interventions: Drug: sulphadoxine/pyrimethamine;   Drug: Chlorproguanil/dapsone;   Drug: Sulfadoxine/pyrimethamine

Indicates status has not been verified in more than two years